Pharmaceutical Technology spoke with Colleen Floreck, vice president, Global Marketing and Strategy, Catalent Cell and Gene Therapy about the specific requirements and challenges for expanding ...
London, Oct. 11, 2022 (GLOBE NEWSWIRE) -- Roots Analysis has announced the addition of “Viral Vector Manufacturing, Non-Viral Vector Manufacturing and Gene Therapy Manufacturing Market, 2022-2035” ...
New York, Dec. 29, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Viral and Non-Viral Vector Manufacturing Market: Focus on Vector Type, Application, Disease and ...
The Viral Vector and Plasmid DNA Manufacturing Market refers to the industrial processes and services that enable the production of viral vectors and plasmid DNA used in gene therapies, vaccine ...
The global viral vector manufacturing market is projected to expand at a robust CAGR of approximately 20% over the forecast period, supported by multiple transformative forces reshaping the ...
Innovation in manufacturing technologies must occur to ensure the availability of gene therapies and cell therapies. The rapid advance of gene and modified cell therapies and growing interest in viral ...
Viral vector-based gene therapies hold immense promise for treating a multitude of diseases. However, their widespread adoption has been hindered by inefficient manufacturing methods and the absence ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback